Overview

Study of Antiinflammatory Effects of Detralex (Daflon)

Status:
Completed
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
Aim of the study: To investigate if there is a differences in expression of inflammatory markers in venous wall and blood among patients treated with Detralex and those not treated with Detralex (control group).
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital Dubrava
Collaborator:
Servier
Treatments:
Anti-Inflammatory Agents